Adipex-P, DailyMed (2024) Phentermine hydrochloride, PDR Ozempic, DailyMed (2023) Semaglutide, PDR Rybelsus, DailyMed (2024) Wegoby, DailyMed (2024) A review of current guidelines for the treatment of obesity, American Journal of Managed Care (2022) Pharmacologic treatment of overweight and obesity in adults
Sitagliptin is a DPP-4 inhibitor, which helps the body use incretin hormones after meals
As a tripleagonist peptide, it works on three key hormone pathways (GIP, GLP-1, and glucagon receptors) to help regulate appetite, boost calorie burn, and improve the bodys overall metabolic efficiency
Mechanism of Action GHK-Cu exerts its biological effects through multiple interconnected mechanisms, acting both as a signalling molecule and a copper delivery system